Updates on AHPA activities and resources delivered to your inbox. Subscribe today!
AHPA has revised its labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for dietary supplements, and is making the updated guidance document available FREE to members.
webPOISONCONTROL® is a free online tool and app that provides immediate triage recommendations and automated follow up for acute, unintentional exposures to a vast array of products and substances.
The June 2021 AHPA Report includes: AHPA has released updates to the Botanical Safety Handbook; AHPA updates GACP-GMP guidance; AHPA updates Primer on CITES; and more!
The Lacey Act of 1900 (the Lacey Act) was originally passed to prohibit the interstate sale and transportation of game killed in violation of local laws. It was modified by the Food, Conservation and Energy Act of 2008 to also address illegal international logging practices and trade.
The American Herbal Products Association (AHPA) delivered a letter to US Trade Representative Katherine Tai this month requesting the removal of punitive tariffs from a range of products relevant to the herbal products industry.
The American Herbal Products Association (AHPA) has updated its guidance document “Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Materials” (AHPA GACP-GMP) to include a new appendix addressing prevention of pyrrolizidine alkaloid contamination.
AHPA has updated its “Primer on Importing and Exporting CITES-Listed Species,” a free resource that provides the herbal industry with the latest information on the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).
A recent California Assembly Bill 1341 (AB 1341) that would place heavy restrictions on a broad range of dietary supplements has been held up in the state Appropriations Committee, seriously delaying its passage.
Silver Spring, MD, May 19, 2021 – Today, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace.